Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study.

Job P van KootenRobert A BelderbosJan H von der ThusenMieke J AartsCornelis VerhoefJacobus A BurgersPaul BaasArend G J AalbersAlexander P W M MaatJoachim G J V AertsRobin CornelissenEva V E Madsen

Published in: Thorax (2022)

The peak of MM incidence was reached around 2010 in the Netherlands, and currently the incidence is declining in most age groups. The use of systemic chemotherapy increased from 2003, which likely resulted in improved overall survival over time. The majority of patients do not receive treatment though and prognosis is still poor.

Keyphrases

risk factors
end stage renal disease
ejection fraction
peritoneal dialysis
combination therapy
squamous cell carcinoma
prognostic factors
drug induced